Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Functional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)

NCT01329471 is registered in ClinicalTrials.gov with Hillel Yaffe Medical Center as lead sponsor.

NCT NCT01329471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01329471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Functional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)
Lead sponsor
Hillel Yaffe Medical Center
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2011
Completion date
April 30, 2013
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia